Literature DB >> 22912558

Excisional hemorrhoidal surgery and its effect on anal continence.

Yan-Dong Li1, Jia-He Xu, Jian-Jiang Lin, Wei-Fang Zhu.   

Abstract

AIM: To investigate the role of anal cushions in hemorrhoidectomy and its effect on anal continence of the patients.
METHODS: Seventy-six consecutive patients (33 men and 43 women) with a mean age of 44 years were included. They underwent Milligan-Morgan hemorrhoidectomy because of symptomatic third- and fourth-degree hemorrhoids and failure in conservative treatment for years. Wexner score was recorded and liquid continence test was performed for each patient before and two months after operation using the techniques described in our previous work. The speed-constant rectal lavage apparatus was prepared in our laboratory. The device could output a pulsed and speed-constant saline stream with a high pressure, which is capable of overcoming any rectal resistance change. The patients were divided into three groups, group A (< 900 mL), group B (900-1200 mL) and group C (> 1200 mL) according to the results of the preoperative liquid continence test.
RESULTS: All the patients completed the study. The average number of hemorrhoidal masses excised was 2.4. Most patients presented with hemorrhoidal symptoms for more than one year, including a mean duration of incontinence of 5.2 years. The most common symptoms before surgery were anal bleeding (n = 55), prolapsed lesion (n = 34), anal pain (n = 12) and constipation (n = 17). There were grade III hemorrhoids in 39 (51.3%) patients, and grade IV in 37 (48.7%) patients according to Goligher classification. Five patients had experienced hemorrhoid surgery at least once. Compared with postoperative results, the retained volume in the preoperative liquid continence test was higher in 40 patients, lower in 27 patients, and similar in the other 9 patients. The overall preoperative retained volume in the liquid continence test was 1130.61 ± 78.35 mL, and postoperative volume was slightly decreased (991.27 ± 42.77 mL), but there was no significant difference (P = 0.057). Difference was significant in the test value before and after hemorrhoidectomy in group A (858.24 ± 32.01 mL vs 574.18 ± 60.28 mL, P = 0.011), but no obvious difference was noted in group B or group C. There was no significant difference in Wexner score before and after operation (1.68 ± 0.13 vs 2.10 ± 0.17, P = 0.064). By further stratified analysis, there was significant difference before and 2 months after operation in group A (2.71 ± 0.30 vs 3.58 ± 0.40, P = 0.003). In contrast, there were no significant differences in group B or group C (1.89 ± 0.15 vs 2.11 ± 0.19, P = 0.179; 0.98 ± 0.11 vs 1.34 ± 0.19, P = 0.123).
CONCLUSION: There is no difference in the continence status of patients before and after Milligan-Morgan hemorrhoidectomy. However, patients with preoperative compromised continence may have further deterioration of their continence, hence Milligan-Morgan hemorrhoidectomy should be avoided in such patients.

Entities:  

Keywords:  Anal cushion; Anal incontinence; Hemorrhoidectomy; Liquids continence test; Wexner score

Mesh:

Year:  2012        PMID: 22912558      PMCID: PMC3420004          DOI: 10.3748/wjg.v18.i30.4059

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  The nature of haemorrhoids.

Authors:  W H Thomson
Journal:  Br J Surg       Date:  1975-07       Impact factor: 6.939

2.  Comparative analysis of summary scoring systems in measuring fecal incontinence.

Authors:  Moo-Kyung Seong; Sung-Il Jung; Tae-Won Kim; Hee-Kyung Joh
Journal:  J Korean Surg Soc       Date:  2011-11-01

3.  Prospective comparison of faecal incontinence grading systems.

Authors:  C J Vaizey; E Carapeti; J A Cahill; M A Kamm
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

4.  [Comparison of long-term efficacy on severe hemorrhoids between procedure for prolapse and hemorrhoids and Milligan-Morgan hemorrhoidectomy].

Authors:  Jian-hua Ding; Ke Zhao; Ren-xiu Jiang; Jun Zhu; Shu-hui Yin; Yu-zhen Kong; Hai-yan Tang
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2009-07

5.  Role of anal cushions in maintaining continence.

Authors:  C P Gibbons; E A Trowbridge; J J Bannister; N W Read
Journal:  Lancet       Date:  1986-04-19       Impact factor: 79.321

Review 6.  Etiology and management of fecal incontinence.

Authors:  J M Jorge; S D Wexner
Journal:  Dis Colon Rectum       Date:  1993-01       Impact factor: 4.585

7.  The anal cushions--a fresh concept in diagnosis.

Authors:  H Thomson
Journal:  Postgrad Med J       Date:  1979-06       Impact factor: 2.401

8.  Randomized clinical trial of the effects on anal function of Milligan-Morgan versus Ferguson haemorrhoidectomy.

Authors:  H O Jóhannsson; L Påhlman; W Graf
Journal:  Br J Surg       Date:  2006-10       Impact factor: 6.939

9.  Haemorrhoidectomy and disordered rectal and anal physiology in patients with prolapsed haemorrhoids.

Authors:  Y H Ho; F Seow-Choen; H S Goh
Journal:  Br J Surg       Date:  1995-05       Impact factor: 6.939

Review 10.  Haemorrhoids: pathology, pathophysiology and aetiology.

Authors:  P B Loder; M A Kamm; R J Nicholls; R K Phillips
Journal:  Br J Surg       Date:  1994-07       Impact factor: 6.939

View more
  2 in total

1.  Defective Conduction of Anorectal Afferents Is a Very Prevalent Pathophysiological Factor Associated to Fecal Incontinence in Women.

Authors:  Lluís Mundet; Christopher Cabib; Omar Ortega; Laia Rofes; Noemí Tomsen; Sergio Marin; Carla Chacón; Pere Clavé
Journal:  J Neurogastroenterol Motil       Date:  2019-07-01       Impact factor: 4.924

2.  The ligament of Parks as a key anatomical structure for safer hemorrhoidectomy: Anatomic study and a simple surgical note.

Authors:  Menelaos Zoulamoglou; Ioannis Kaklamanos; Maria Zarokosta; Ioannis Flessas; Vasileios Bonatsos; Theodoros Piperos; Panagiotis Theodoropoulos; Georgia Barla; Ioanna Stathopoulou; Theodoros Mariolis-Sapsakos
Journal:  Ann Med Surg (Lond)       Date:  2017-10-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.